Zotatifin continues to show favorable activity profile, including two confirmed partial responses (PR) among seven heavily pretreated...

The 1950s are widely recognized as one of the most important decades in biology. This is, in large part, due to the discovery of the...

Phase 1b study designed to determine the safety and dose of NUV-868 in combination with olaparib or enzalutamide for the treatment of...

- Study will assess the safety, efficacy and engraftment of FB-001 for the treatment of enteric hyperoxaluria, a serious metabolic...

Financing led by New Enterprise Associates (NEA), Abingworth and Forge Life Science Partners Proceeds support advancement of EP262 and...

MEMPHIS, Tenn., Nov. 22, 2022 /PRNewswire/ -- Indigo Agriculture today announced the commercial launch of the industry's first biological...

Proceeds to support the advancement of Neumora’s mission of building a leading global precision neuroscience company to revolutionize the...

Dose escalation based on positive recommendation from independent data safety monitoring board after safety review of cohort 1 Drug...

Paper reports that Gritstone’s tumor-specific, neoantigen vaccination approach drives priming and boosting of tumor-specific T cells,...